AABB recently launched a new toolkit to assist transfusion services that must register with the Food and Drug Administration for the first time because they are implementing a bacterial detection test to extend the expiration of platelets to day 6 or 7 and relabel the platelets.
The 2021 Virtual Annual Meeting will feature a robust program of expert-led education sessions, oral and poster abstract presentations covering the latest research, and a virtual exhibit hall showcasing new products from industry partners.
AABB created a fact sheet to address frequently asked questions (FAQs) related to COVID-19 blood donation and transfusion for donors, clinicians and patients.
Complimentary registration is available for the upcoming Science & Innovation Forum that will explore the mitigation of bacterial risk in platelets from the perspective of blood centers and transfusion services. Presented by Cerus Corporation, the program will take place at 2 p.m. ET on April 15.
